Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Sciensus Appoints James Tugendhat OBE as Its Chief Executive Officer

also generates real-world evidence that helps demonstrate the value of treatments and improve future care. For more information please visit, www.sciensus.com

KODAK PHARMACEUTICALS Expands Its Portfolio and Launches an Online Store in the U.S

next step in Kodak’s phased expansion of its pharmaceutical portfolio, which includes Water for Injection and multiple PBS formulations, with additional products planned. Kodak is also progressing toward the introduction of Class II products as...

Alchemy 21/12 Introduces Oleotide™, a Breakthrough Modular Biotechnology Platform for Advanced Skincare

Alchemy 21/12 introduced Oleotide™ — a modular biotechnology platform built around the coordination of biological signals and the conditions that support skin renewal. The company describes its first-of-its-kind architecture through five...

CELSET Launches Korean Botulinum Toxin Type A Brand SOLTOX in International Markets

botulinum toxin brand to the international medical aesthetics industry. SOLTOX is presented in 100 Unit and 200 Unit formulations with three defining technical characteristics: a 900 kDa toxin complex, a freeze dried dosage form, and an advanced...

Stevanato Group and Aptar Pharma Collaborate to Accelerate Pre-Filled Syringe System Selection

July 2026, and brings complementary expertise together across the injectable value chain. As biologics, high-concentration formulations, and combination products continue to increase in complexity, pharma companies face growing challenges in...

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

alongside a preprint in bioRxiv introducing Pythia-1, the all-atom generative model at the core of its antibody design platform. Pythia’s technology is built to create antibodies against targets that have challenged conventional discovery,...

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

alongside a preprint in bioRxiv introducing Pythia-1, the all-atom generative model at the core of its antibody design platform. Pythia’s technology is built to create antibodies against targets that have challenged conventional discovery,...

MEPSGEN Launched NanoCalibur® Mini for Nanoparticle Formulation in Small Volumes

MEPSGEN US, Inc., a global innovator in drug delivery system platforms, announced the launch of NanoCalibur® Mini, an automated system for small-volume nanoparticle formulation designed for early-stage drug discovery and development. Nanoparticles...

Aptar Pharma Expands Next-Generation Pulmonary Drug Delivery Capabilities with Acquisition of Pulmotree

the development, industrialization and commercialization of PULMOTREE’s Kolibri™ Non-Propellant Liquid Inhaler (NPLI) platform. The acquisition is intended to expand Aptar Pharma’s opportunities for growth in respiratory drug delivery by adding a...

Niagen Bioscience Launched Niagen™ Plus Liquid At-Home Injections to Support Its Telehealth Expansion

prescription-only pharmaceutical-grade Niagen™ At-Home Injection Kit, featuring the Company’s first ready-to-inject liquid formulation with Niagen™ (patented nicotinamide riboside, or NR), the most studied, high-quality NAD+ precursor brand...

Aptar Appoints Pharma Packaging Veteran Virginie Maes as President of its Pharma Business

strategy and business development. She brings extensive experience in global customer relationships, growth and transformation, operational performance and building highly engaged teams. Earlier in her career, Maes worked at McKinsey & Company,...

Zai Lab Reports High Response Rates, Encouraging Durability, and a Favorable Safety Profile for Zocilurtatug Pelitecan (Zoci; Formerly ZL-1310) in First-Line Extensive-Stage Small Cell Lung Cancer

biopharma company, shared the first data from a global Phase 1b clinical trial evaluating zocilurtatug pelitecan (zoci, formerly ZL-1310) in combination with atezolizumab with and without carboplatin as first-line treatment for extensive-stage...

Global Pharma Supply Chain & Logistics Forum 2026

Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. This exclusive platform explores cutting-edge innovations in AI, IoT, blockchain, and cold chain logistics, while fostering valuable networking and...

Niagen Bioscience Establishes Skincare as a Permanent Tru Niagen® Category with the Launch of Dermatologist-Tested Niagen NanoCloud™ as a Core Product

the first dermatologist-tested topical product powered by Niagen® (patented nicotinamide riboside, or NR, a unique form of vitamin B3), the same ingredient in Tru Niagen® supplements, now in topical form. Delivered in a waterless, precision-dosed...

2nd International Conference on Drug Discovery 2026

and biotechnology. Scheduled to take place on October 12–13, 2026, in Singapore, the conference serves as a global platform to exchange knowledge, discuss emerging trends, and foster collaborations that accelerate drug discovery and therapeutic...

NextGen Pharma 2026

brings together scientists, researchers, industry leaders, regulators, and healthcare professionals to discuss transformative advancements in drug discovery, development, delivery systems, personalized medicine, and digital health. At NextGen...

BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

AGILITY, the results demonstrated strong safety and effectiveness outcomes in patients with iliac artery disease, a common form of peripheral artery disease (PAD). The findings mark an important milestone in the efforts by BD to expand clinical...

The meeting will focus on Nordic Pharma, Inc.’s patient data and study results on LACRIFILL® Canalicular Gel, a novel ocular surface therapy

working with SEVER Life Sciences / Nordic Pharma, and other factors that could influence the business and financial performance of SEVER Life Sciences / Nordic Pharma. SEVER Life Sciences / Nordic Pharma assumes no obligation to publicly update any...

Arkayli Biopharma Inc. Receives FDA Study May Proceed Response to IND and NIH SBIR Grant to Advance Clinical Development of ARK001 for a Rare Pediatric Disease

thus far" said Thomas Rossi, PhD, Chairman of the Board of Arkayli Biopharma, Inc., "completing the preclinical research, formulation, and manufacturing preparation to support the IND filing. We look forward to entering the clinic with ARK001."...

Carterra Advances Drug Discovery Through New Lab-In-The-Loop Scientific Collaboration

Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing...